As of January 2026 Halozyme Therapeutics has a market cap of ยฃ6.32 Billion. This makes Halozyme Therapeutics the world's 2222th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 12th, 2026 the market cap of Halozyme Therapeutics was reported to be: